Post-embolization Pain
Post-embolization Pain - Related Videos
14:56
An Experimental Paradigm for the Prediction of Post-Operative Pain (PPOP)
0 Views •
Cited by 107 •
2010
Diffuse noxious inhibitory control, temporal summation and wound hyperalgesia testing are demonstrated in the obstetric patient. These tests evaluate inhibitory and excitatory mechanisms of pain processing and are here utilized to evaluate endogenous analgesia at different time-points during pregnancy and the peripartum period to help reveal individual s risk for persistent pain.
![Autoradiographic Measurements of [<sup>14</sup>C]-Iodoantipyrine in Rat Brain Following Central Post-Stroke Pain](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F53947.jpg%3Fv%3D2026-09-01%252006%253A32%253A11&w=750&q=75)
07:27
Autoradiographic Measurements of [14C]-Iodoantipyrine in Rat Brain Following Central Post-Stroke Pain
0 Views •
Cited by 1 •
2016
We present a protocol to measure [14C]-iodoantipyrine (IAP) uptake and assess the activation of neural substrates that are involved in central post-stroke pain (CPSP) in a rodent model.
03:06
Combination of High Ligation and Intraoperative Embolization Using Polidocanol for Treatment of Varicoceles
0 Views •
2023
To reduce the postoperative recurrence rate of varicocelectomy, we combined high ligation of varicocele with intraoperative embolization. We injected polidocanol from the spermatic vein during surgery to embolize the branches of the spermatic vein and collateral veins. This is an alternative surgical method for the treatment of varicocele.
07:12
Chronic Post-Ischemia Pain Model for Complex Regional Pain Syndrome Type-I in Rats
0 Views •
Cited by 15 •
2020
Provided here is a protocol that details steps to establish an animal model of chronic post-ischemia pain (CPIP). This is a well-recognized model mimicking human complex regional pain syndrome type-I. Mechanical and thermal hypersensitivities are further evaluated, as well as capsaicin-induced nocifensive behaviors observed in the CPIP rat model.
08:29
Microvascular Embolism Mouse Model for In Vivo Two-photon Microscopy Using Fluorescent Polystyrene Microspheres
0 Views •
2025
This protocol contains a thorough description of a step-by-step approach for a chronic cranial window and microvascular embolism mouse model optimized for in vivo two-photon microscopy imaging using fluorescent polystyrene microspheres.
FAQs
Pain after embolization reflects more than a single mechanism. Reduced blood flow lowers oxygen delivery, producing temporary ischemia, while local inflammation and tissue injury add inflammatory discomfort. In organs where swelling occurs, enlargement or capsular distention can further stimulate pain. Considering these mechanisms helps clinicians interpret discomfort as a treatment-related response rather than an unexplained symptom.
Swelling can intensify discomfort in organs enclosed by a capsule because expanding tissue increases capsular distention. This mechanism differs from pain caused directly by reduced oxygen delivery or local tissue injury, although the processes can occur together. The treated organ therefore matters when clinicians anticipate severity and determine how closely recovery should be followed.
Pain severity and duration are not uniform across procedures. The treated site, the type of embolic material, and the extent of vessel or tissue occlusion all influence the response. These variables alter how much ischemia, inflammation, injury, or swelling develops, so clinicians should interpret the patient’s experience in the context of the specific embolization rather than apply one expected pattern.
Recognizing the usual treatment-related mechanisms provides a baseline for judging whether discomfort fits the expected response. Clinicians must also consider complications, including infection and non-target ischemia, which can produce clinically important problems after the intended vessel is occluded. The distinction matters because appropriate analgesia supports recovery, whereas possible complications require clinical evaluation rather than symptom control alone.
Appropriate analgesia is part of post-procedure care because ischemia, inflammation, tissue injury, and possible swelling can cause discomfort. Treatment should support recovery while clinicians continue to assess whether the pain remains consistent with the expected response. Symptom relief therefore does not replace recognition of infection or non-target ischemia, but complements ongoing clinical assessment.
It is relevant whenever embolization treats a tumor, vascular malformation, or bleeding, because the targeted tissue and degree of occlusion can differ. Anticipating pain helps clinicians plan appropriate analgesia and support recovery, while awareness of the expected response aids recognition of infection or non-target ischemia across these treatment settings.